Satellos Bioscience's total assets for Q3 2025 were C$37.50M, a decrease of -8.79% from the previous quarter. MSCLF total liabilities were C$3.50M for the fiscal quarter, a 26.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.